Light-based therapy reduces pain associated with peripheral diabetic neuropathy, study concludes
A study conducted at the Federal University of São Paulo (UNIFESP) in Brazil has concluded that the use of monochromatic ...
TheraFoot Pro Reviews - Can It Really Relieve Foot Pain?
In this review, we'll cover all you need to know about the TheraFoot Pro foot massager, including how it treats foot pain and ...
Fox2Now St. Louis5d
Neuropathy is becoming a bigger problem for more people than ever before
SPONSORED – If you’re suffering from stabbing pain, numbness, tingling or a burning sensation in your arms, legs, hands or feet, you may be experiencing peripheral neuropathy. If you or a ...
Nottinghamshire Live on MSN1d
Common nighttime habit could be 'red flag' sign of diabetes
An expert has flagged the common signs of diabetes, including a common nighttime habit. As World Diabetes Day was marked on ...
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain
Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...
World Diabetes Day 2024: Simple ways to treat, prevent diabetic foot diseases and foot ulcers
Here's how diabetic foot diseases and foot ulcers are caused, who is at risk, signs to watch and expert tips to prevent or ...
GlobalData on MSN8d
Averitas completes recruitment for trial of QUTENZA to treat post-surgical pain
Averitas Pharma, the US subsidiary of Grünenthal, has completed patient recruitment for the Phase III AV001 clinical study, ...
ots10d
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neur
The Phase III trial AV001 aims to evaluate QUTENZA® in post- surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after ...